Showing results (161-170 of 169) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Plos One|February 9, 2021
Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort StudyBrittanny M Polanka, Suman Kundu, Kaku A So-Armah, et al.Journal of Clinical Microbiology|May 1, 2020
Multicenter Evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for Detection and Quantification of Agents of Lower Respiratory Tract InfectionCaitlin N Murphy, Randal Fowler, Joan Miquel Balada-Llasat, et al.Annals of Internal Medicine|October 7, 2024
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized TrialKathleen V Fitch, Markella V Zanni, Jennifer Manne-Goehler, et al.The Lancet. HIV|June 7, 2020
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trialsChloe Orkin, Edwin DeJesus, Paul E Sax, et al.Circulation|September 12, 2015
Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort StudyJessica R White, Chung-Chou H Chang, Kaku A So-Armah, et al.The Pharmacogenomics Journal|September 9, 2023
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trialMichael T Eadon, Marc B Rosenman, Pengyue Zhang, et al.AIDS (London, England)|April 2, 2019
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trialsSamir K Gupta, Frank A Post, José R Arribas, et al.The New England Journal of Medicine|July 29, 2026
Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 TreatmentJürgen K Rockstroh, Moti N Ramgopal, Adrian Curran Fàbregas, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2025
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIVSteven K Grinspoon, Maya Watanabe, Heather J Ribaudo, et al.Pageof 17